🌱 KidneyEnergy.com

← brief for 2026-10-24 · Regeneration & devices

CYP1B1 is a potential target of kaempferol in renal fibrosis: a multi‑omics and single‑cell transcriptomics study.

Article D Peer reviewed Preclinical

Key takeaways

This study looked at how a plant compound called kaempferol affects kidney scarring. It used computer models and cell data to find a target called CYP1B1. This was done in cells and data, not in people yet. It suggests a new path for treating kidney damage.

Who did this work

Huang C (School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, China.) · Shi X (Zhuang Medicine College, Guangxi University of Chinese Medicine, Nanning, Guangxi Province, China.) · Yan Z (School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, China. [email protected].)

Source

Article · Europe PMC, CKD · 2026-10-20
https://doi.org/10.1186/s40643-026-01135-z